Rockwell Medical Inc
RMTI1.040USD
0.000
收盤 11/05, 16:00（美東）報價延遲15分鐘
35.81M總市值
虧損本益比TTM
關於 Rockwell Medical Inc 公司
Rockwell Medical, Inc. 是一家醫療保健公司。該公司爲世界各地的透析提供商開發、製造、銷售和分銷一系列血液透析產品。該公司在血液透析市場開展業務，涉及製造、銷售和分銷血液透析產品給血液透析診所，包括透析過程中使用的藥品、透析濃縮液、透析套件和其他輔助產品。該公司是透析診所維持生命的血液透析濃縮液產品的供應商。其血液透析濃縮液產品用於通過清除毒素和平衡透析患者血液中的電解質來維持患者的生命。該公司在密歇根州、南卡羅來納州和德克薩斯州的工廠生產血液透析濃縮液，並在愛荷華州的工廠生產幹酸濃縮液混合器。
Rockwell Medical Inc簡介
公司代碼RMTI
公司名稱Rockwell Medical Inc
上市日期Jan 27, 1998
CEODr. Mark Strobeck, Ph.D.
員工數量244
證券類型Ordinary Share
年結日Jan 27
公司地址30142 Wixom Road
城市WIXOM
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編48393
電話18004493353
網址https://www.rockwellmed.com/
公司代碼RMTI
上市日期Jan 27, 1998
CEODr. Mark Strobeck, Ph.D.
Rockwell Medical Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+52.38%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Director
Independent Director
142.06K
+54.31%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
105.95K
-0.83%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer
Chief Operating Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+52.38%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Director
Independent Director
142.06K
+54.31%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
收入明細
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%
地區USD
名稱
營收
佔比
United States
14.19M
0.00%
Rest of World
1.88M
0.00%
業務
地區
業務USD
名稱
營收
佔比
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%
股東統計
更新時間: 10月14日 週二
更新時間: 10月14日 週二
持股股東
股東類型
持股股東
持股股東
佔比
Irrevocable Larson Family Investment Trust
10.33%
Armistice Capital LLC
6.24%
The Vanguard Group, Inc.
3.50%
Renaissance Technologies LLC
1.57%
Geode Capital Management, L.L.C.
0.93%
其他
77.42%
持股股東
持股股東
佔比
Irrevocable Larson Family Investment Trust
10.33%
Armistice Capital LLC
6.24%
The Vanguard Group, Inc.
3.50%
Renaissance Technologies LLC
1.57%
Geode Capital Management, L.L.C.
0.93%
其他
77.42%
股東類型
持股股東
佔比
Corporation
10.33%
Hedge Fund
8.13%
Investment Advisor
6.31%
Individual Investor
4.74%
Investment Advisor/Hedge Fund
2.66%
Research Firm
0.10%
其他
67.73%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
98
5.92M
17.19%
-2.11M
2025Q2
119
12.15M
35.56%
-1.45M
2025Q1
124
11.25M
32.97%
-1.96M
2024Q4
123
12.47M
38.59%
-1.21M
2024Q3
113
13.08M
41.13%
+2.79M
2024Q2
102
9.50M
31.23%
+460.06K
2024Q1
118
5.89M
19.90%
-1.12M
2023Q4
118
5.97M
23.48%
-688.25K
2023Q3
122
6.04M
24.13%
+2.56M
2023Q2
133
3.92M
24.44%
+947.21K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Irrevocable Larson Family Investment Trust
3.56M
10.33%
+87.50K
+2.52%
Apr 11, 2025
Armistice Capital LLC
2.15M
6.24%
-216.67K
-9.16%
Jun 30, 2025
The Vanguard Group, Inc.
1.21M
3.5%
--
--
Jun 30, 2025
Renaissance Technologies LLC
541.75K
1.57%
+88.75K
+19.59%
Jun 30, 2025
Geode Capital Management, L.L.C.
320.67K
0.93%
-3.87K
-1.19%
Jun 30, 2025
GlobeFlex Capital, L.P.
312.06K
0.91%
-431.20K
-58.02%
Jun 30, 2025
Strobeck (Mark)
290.62K
0.84%
-6.93K
-2.33%
Jul 01, 2025
BlackRock Institutional Trust Company, N.A.
217.66K
0.63%
+1.98K
+0.92%
Jun 30, 2025
Marshall Wace LLP
173.78K
0.5%
-159.82K
-47.91%
Jun 30, 2025
Ravich (Mark H)
151.10K
0.44%
+50.00K
+49.45%
May 20, 2025
查看更多
持股ETF
更新時間: 11月2日 週日
更新時間: 11月2日 週日
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
佔比0.01%
Dimensional US Core Equity 1 ETF
佔比0%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
公告日期
類型
比率
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
